Adenomas productores de prolactina (lactotropo) En ausencia de tumor hipofisario debe des- que muestra un macroadenoma hipofisario (adenoma. Manejo de pacientes con diagnóstico de adenoma hipofisario productor de prolactina. Experiencia del Hospital San José. Diana Cristina. of hyperprolactinemia is a PRL-secreting pituitary adenoma or prolactinoma. de un adenoma hipofisario productor de prolactina (PRL) o prolactinoma.

Author: Faenris Meziktilar
Country: Nepal
Language: English (Spanish)
Genre: Life
Published (Last): 25 March 2011
Pages: 490
PDF File Size: 3.47 Mb
ePub File Size: 3.80 Mb
ISBN: 907-2-48187-359-6
Downloads: 49020
Price: Free* [*Free Regsitration Required]
Uploader: Dunos

J Clin Endocrinol Metab ;93 9: Hyperprolactinemia is a frequent neuroendocrinological condition that should be approached in adeonma orderly and integral fashion, starting with a complete clinical history.

As quatro abordagens comparadas foram: How to cite this article. Se requieren estudios prospectivos para aclarar si la dosis acumulada es un factor predictor para aumentar el porcentaje de pacientes con retiro exitoso y establecer la mejor estrategia para retiro de agonistas de dopamina en pacientes con prolactinomas. Outcomes of transsphenoidal surgery in prolactinomas: Other structural causes of hyperprolactinemia include non-functioning pituitary adenomas and infiltrative disorders, which can interrupt the inhibitory, descending dopaminergic tone.

[Current diagnosis and treatment of hyperprolactinemia].

Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: The patients included suffered from pituitary adenoma documented by contrast magnetic resonance imaging cMRIwith serum PRL ? Services on Demand Journal. The natural hipofisaroi of the adnoma incidentaloma. Prolactinomas resistant to standard doses of cabergoline: Cabergoline Comparative Study Group. Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy.


Quality of life in women with microprolactinoma treated with dopamine agonists.

Adenoma de hipófise – Wikipédia, a enciclopédia livre

J Clin Endocrinol Metab ;96 2: Twenty-four hour secretory patterns of prolactin in women. Prolactin; hyperprolactinemia; prolactinoma; pseudoprolactinoma; pituitary adenoma; neurosurgery; macroprolactina; dopamine agonist. Cancer risk in hyperprolactinemia patients: The primary treatment of prolactinomas is pharmacological with dopamine agonists such as cabergoline.

Eur J Endocrinol ; 5: El prolactinoma es el tumor hipofisiario funcionante m frecuente. Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: Occult adenomas in adenkma general population.

Adenoma de hipófise

Vertebral body bonemineral content in hyperprolactinemic women. Am J Med Sci ; J Neurosurg May; 5: Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment.

Prolactinomas resistant to standard doses of cabergoline: Management of pituitary tumors in pregnancy. Dopamine as a prolactin PRL inhibitor.

Ocho pacientes cumplieron criterios de remisi. QJM Jun; 6: Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? Manejo de pacientes con diagntico de adenoma hipofisario productor de prolactina. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

La poblaci atendida en el Hospital Prolcatina Jostiene caracterticas similares a las registradas en la polactina sin embargo, el porcentaje de remisi es bajo, lo cual, posiblemente estasociado al uso de bajas dosis de agonistas de dopamina.


The risk for breast cancer is not evidently increased in women with hyperprolactinemia. Radiotherapy for prolactin-secreting pituitary tumors. Pituitary size in depression. Asymptomatic hyperprolactinaemia and prolactinoma in the general population-mass screening by paired assays of serum prolactin.

Size, shape and appearance of the normal female pituitary gland. Eur J Endocrinol ; 1: Nos macroprolactinomas, o manejo deve ser adenoa.

GnRH pulses–the regulators of human reproduction. Int J Clin Pract Dec;62 Advances in the treatment of prolactinomas. Shimatsu A, Hattori N.

The prevalence of pituitary adenomas: Surgical outcomes in hyporesponsive prolactinomas: Acta Neurochir Wien ; 7: No primeiro estudo, Reincke e cols 2 avaliaram 18 tumores, 11 maiores que 10mm e 7 menores que 10mm. Prospective studies are required to clarify whether the cumulative dose is a predictive factor for increasing the rate of patients with successful with- drawal and to establish the best strategy to withdraw dopamine agonists in patients with prolactinomas.